{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:37:06Z","timestamp":1777415826165,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,1,28]],"date-time":"2014-01-28T00:00:00Z","timestamp":1390867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s12185-014-1505-2","type":"journal-article","created":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T09:31:12Z","timestamp":1390815072000},"page":"519-522","source":"Crossref","is-referenced-by-count":11,"title":["Successful allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning for B-cell prolymphocytic leukemia in partial remission"],"prefix":"10.1007","volume":"99","author":[{"given":"Hiroshi","family":"Arima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumie","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisako","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,28]]},"reference":[{"key":"1505_CR1","first-page":"183","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"E Campo","year":"2008","unstructured":"Campo E, Catovsky D, Montserrat E, M\u00fcller-Hermelink H, Harris N, Stein H. B-cell prolymphocytic leukemia. In: Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2008. p. 183\u20134."},{"key":"1505_CR2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1600-0609.2008.01069.x","volume":"80","author":"M Dungarwalla","year":"2008","unstructured":"Dungarwalla M, Matutes E, Dearden C. Prolymphocytic leukaemia of B-and T-cell subtype: a state-of-the-art paper. Eur J Haematol. 2008;80:469\u201376.","journal-title":"Eur J Haematol"},{"key":"1505_CR3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/blood-2003-05-1406","volume":"103","author":"RD Faulkner","year":"2004","unstructured":"Faulkner RD, Craddock C, Byrne JL, Mahendra P, Haynes AP, Prentice HG, et al. BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients. Blood. 2004;103:428\u201334.","journal-title":"Blood"},{"key":"1505_CR4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11864-005-0003-4","volume":"6","author":"A Absi","year":"2005","unstructured":"Absi A, Hsi E, Kalaycio M. Prolymphocytic leukemia. Curr Treat Options Oncol. 2005;6:197\u2013208.","journal-title":"Curr Treat Options Oncol"},{"key":"1505_CR5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbmt.2009.11.021","volume":"16","author":"ME Kalaycio","year":"2010","unstructured":"Kalaycio ME, Kukreja M, Woolfrey AE, Szer J, Cortes J, Maziarz RT, et al. Allogeneic hematopoietic cell transplant for prolymphocytic leukemia. Biol Blood Marrow Transpl. 2010;16:543\u20137.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1505_CR6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/blood-2002-12-3629","volume":"102","author":"M Mohty","year":"2003","unstructured":"Mohty M, Bay JO, Faucher C, Choufi B, Bilger K, Tournilhac O, et al. Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin\u2013based reduced-intensity preparative regimen. Blood. 2003;102:470\u20136.","journal-title":"Blood"},{"key":"1505_CR7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12185-013-1313-0","volume":"97","author":"SFA Wahid","year":"2013","unstructured":"Wahid SFA. Indications and outcomes of reduced-toxicity hematopoietic stem cell transplantation in adult patients with hematological malignancies. Int J Hematol. 2013;97:581\u201398.","journal-title":"Int J Hematol"},{"key":"1505_CR8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12185-013-1430-9","volume":"98","author":"Y Ito","year":"2013","unstructured":"Ito Y, Miyamoto T, Kamimura T, Takase K, Henzan H, Sugio Y, et al. Clinical outcomes of allogeneic stem cell transplantation for relapsed or refractory follicular lymphoma: a retrospective analysis by the Fukuoka Blood and Marrow Transplantation Group. Int J Hematol. 2013;98:463\u201371.","journal-title":"Int J Hematol"},{"key":"1505_CR9","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"J Dongen Van","year":"2003","unstructured":"Van Dongen J, Langerak A, Br\u00fcggemann M, Evans P, Hummel M, Lavender F, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia. 2003;17:2257\u2013317.","journal-title":"Leukemia"},{"key":"1505_CR10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/leu.2008.5","volume":"22","author":"T Flohr","year":"2008","unstructured":"Flohr T, Schrauder A, Cazzaniga G, Panzer-Gr\u00fcmayer R, Van Der Velden V, Fischer S, et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia. 2008;22:771\u201382.","journal-title":"Leukemia"},{"key":"1505_CR11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/sj.bmt.1705626","volume":"39","author":"S Talwar","year":"2007","unstructured":"Talwar S, Khan F, Nityanand S, Agrawal S. Chimerism monitoring following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2007;39:529\u201335.","journal-title":"Bone Marrow Transpl"},{"key":"1505_CR12","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.3109\/10428194.2013.788697","volume":"54","author":"H Arima","year":"2013","unstructured":"Arima H, Maruoka H, Nasu K, Tabata S, Kurata M, Matsushita A, et al. Impact of occult bone marrow involvement on the outcome of rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone therapy for diffuse large B-cell lymphoma. Leuk Lymphoma. 2013;54:2645\u201353.","journal-title":"Leuk Lymphoma"},{"key":"1505_CR13","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/sj.bmt.1704991","volume":"35","author":"L Castagna","year":"2005","unstructured":"Castagna L, Sarina B, Todisco E, Mazza R, Santoro A. Allogeneic peripheral stem-cell transplantation with reduced-intensity conditioning regimen in refractory primary B-cell prolymphocytic leukemia: a long-term follow-up. Bone Marrow Transpl. 2005;35:1225.","journal-title":"Bone Marrow Transpl"},{"key":"1505_CR14","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.bbmt.2011.01.016","volume":"17","author":"T Shea","year":"2011","unstructured":"Shea T, Johnson J, Westervelt P, Farag S, McCarty J, Asad B, et al. Reduced intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901. Biol Blood Marrow Transpl. 2011;17:1395\u2013403.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1505_CR15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/10428199909093739","volume":"33","author":"L Shvidel","year":"1999","unstructured":"Shvidel L, Shtalrid M, Bassous L, Klepfish A, Vorst E, Berrebi A. B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course. Leuk Lymphoma. 1999;33:169\u201379.","journal-title":"Leuk Lymphoma"},{"key":"1505_CR16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1034\/j.1600-0609.2003.00007.x","volume":"70","author":"JH Haidar","year":"2003","unstructured":"Haidar JH, Shamseddine A, Salem Z, Mrad YA, Nasr MR, Zaatari G, et al. Loss of CD20 expression in relapsed lymphomas after rituximab therapy. Eur J Haematol. 2003;70:330\u20132.","journal-title":"Eur J Haematol"},{"key":"1505_CR17","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1182\/blood-2008-08-175208","volume":"113","author":"J Hiraga","year":"2009","unstructured":"Hiraga J, Tomita A, Sugimoto T, Shimada K, Ito M, Nakamura S, et al. Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance. Blood. 2009;113:4885\u201393.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1505-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-014-1505-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1505-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:11:16Z","timestamp":1559452276000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-014-1505-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,28]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1505-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,28]]}}}